#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary angioedema Ovarian cancer stage IV Arteriovenous malformation Basal cell naevus syndrome Pulmonary hypertension Ventricular fibrillation Ocular myasthenia Fms-like tyrosine kinase 3 positive Ependymoma Myxofibrosarcoma Behcet's syndrome Polycythaemia vera Encephalitis autoimmune Optic glioma Ichthyosis More trials…

    Learn about Rare Diseases

    Haemophilia A with anti factor VIII – Diagnostics Wolfram syndrome – Trials in Disease Cerebral arteriovenous malformation haemorrhagic – Basic Information Gaucher’s disease type III – Life with Disease Rhabdomyosarcoma recurrent – Treatment Noonan syndrome – Diagnostics Hyperoxaluria – Life with Disease Idiopathic pulmonary fibrosis – Life with Disease Phenylketonuria Familial amyotrophic lateral sclerosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dexamethasone Base Octocog Alfa Glucose, Anhydrous Bimekizumab HUMAN COAGULATION FACTOR XIII Ademetionine Simeticone Ucart22 Bifikafusp Alfa Mva-209-Fsp-B4 Aup1602-C Nicotine Aluminium Oxide Msv-Allo Mk-6194 Propranolol Hydrochloride Quemliclustat Allopurinol Sodium Benzylpenicillin Sodium Tomligisiran More therapies…

    Learn about Your Condition

    Uveal melanoma Hyperthyroidism Muscle strain Polycythaemia vera Brain abscess Abdominal wall pain Neurotrophic keratopathy Acute on chronic liver failure Menopausal symptoms Latent tuberculosis Delayed graft function Viral myocarditis ROHHAD syndrome Neuropathic arthropathy Acute coronary syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study Comparing Methylprednisolone Aceponate Creams and a Non-Active Cream for Patients with Mild to Moderate Atopic Dermatitis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Methylprednisolone Aceponate
    Germany

  • Study on Pain Relief for Limb Injuries in Children: Comparing Intranasal Fentanyl, Intranasal Ketamine, and Oral Morphine in Patients Aged 2-17 Years

    Recruiting

    4 1 1
    Investigated Drugs:
    • Morphine Sulfate
    • Ketamine
    • Sodium Chloride
    France

  • Study on the Dose and Safety of Asciminib in Children with Chronic Myeloid Leukemia

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Juvenile chronic myelomonocytic leukaemia
    • Philadelphia positive chronic myeloid leukaemia
    • Chronic myeloid leukaemia
    Investigated Drugs:
    • Asciminib
    • Asciminib Hydrochloride
    France Germany Greece Hungary Italy The Netherlands +1

  • Study Comparing Standard Care and Targeted Treatment with Telemonitoring for Ulcerative Colitis Patients Using Adalimumab

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Adalimumab
    France

  • Study on Atezolizumab, Bevacizumab, and EXL01 for Patients with Liver Cancer Not Responding to First-Line Immunotherapy

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Exl01
    • Tremelimumab
    • Atezolizumab
    France

  • Study on Dornase Alfa and Placebo to Reduce ARDS in Ventilated Trauma Patients in ICU

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acute respiratory distress syndrome
    Investigated Drugs:
    • Dornase Alfa
    • Sodium Chloride
    France
Previous Page
1 … 492 493 494 495 496 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!